CardioVasc

, Volume 17, Issue 1, pp 34–37 | Cite as

Alternativen zu Hydrochlorothiazid

Differenzialtherapie der Hypertonie mit Diuretika

Fortbildung Hypertonie
First Online:
  • 37 Downloads

Diuretika zählen zu den ältesten Medikamenten gegen Hypertonie, sind jedoch in ihrer Wirkweise nicht völlig verstanden, z. B. hält die blutdrucksenkende Wirkung unabhängig von der Volumenreduktion kontinuierlich an. Um Alternativen zu dem in nahezu allen Kombinationen vorhandenen Diuretikum Hydrochlorothiazid aufzuzeigen, stellt dieser Artikel die differenzialtherapeutischen Prinzipien der Diuretikatherapie bei Hypertonie dar.

This is a preview of subscription content, log in to check access.

Literatur

  1. 1.
    Williams B, MacDonald TM, Morant S et al. Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial. Lancet. 2015;386:2059–68CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Roush GC, Ernst ME, Kostis JB et al. Head-to-head comparisons of hydrochlorothiazide with indapamide and chlorthalidone: antihypertensive and metabolic effects. Hypertension. 2015;65:1041–6CrossRefPubMedGoogle Scholar
  3. 3.
    Olde Engberink RH, Frenkel WJ, van den Bogaard B et al. Effects of thiazide-type and thiazide-like diuretics on cardiovascular events and mortality: systematic review and meta-analysis. Hypertension. 2015;65:1033–40CrossRefPubMedGoogle Scholar
  4. 4.
    Ernst ME, Carter BL, Goerdt CJ et al. Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension. 2006;47:352–8CrossRefPubMedGoogle Scholar
  5. 5.
    Ahamed S, Anpalahan M, Savvas S et al. Hyponatraemia in older medical patients: implications for falls and adverse outcomes of hospitalisation. Intern Med J. 2014;44:991–7CrossRefPubMedGoogle Scholar
  6. 6.
    Araoye MA, Chang MY, Khatri IM, Freis ED. Furosemide compared with hydrochlorothiazide. Long-term treatment of hypertension. JAMA. 1978;240:1863–6CrossRefPubMedGoogle Scholar
  7. 7.
    Agarwal R, Sinha AD, Pappas MK, Ammous F. Chlorthalidone for poorly controlled hypertension in chronic kidney disease: an interventional pilot study. Am J Nephrol. 2014;39:171–82CrossRefPubMedGoogle Scholar
  8. 8.
    Saha C, Eckert GJ, Ambrosius WT et al. Improvement in blood pressure with inhibition of the epithelial sodium channel in blacks with hypertension. Hypertension. 2005;46:481–7CrossRefPubMedGoogle Scholar

Copyright information

© Springer Medizin 2017

Authors and Affiliations

  1. 1.Med. Klinik mit SP NephrologieCharité – Universitätsmedizin Berlin, Campus Benjamin FranklinBerlinDeutschland

Personalised recommendations